We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
DT10 Sports aims to make health more fun and engaging, challenging all that is ordinary, by offering a range of food and drink products specifically for the Sports Fitness, recreation and Exercise Market. The brand is accredited by "Informed Sports" a governing body and globally recognised benchmark for best in class. DT10 Sports believe that a trade sale would be the preferred alternative in terms of added value but will actively consider the most efficient way of unlocking the most suitable value for all shareholders as the business develops. DT10 Sports is now looking for investment for its ‘Go to Market’ Strategy, grow brand awareness, and invest further in its supply chain. 
days to go: Expired investment: £646,150
Spotlight Consultations aims to diagnose diseases based on evidence-based questionnaires. The company's Algorithmic Questionnaire (AQ) strives to be a simple 3-5 minute questionnaire, dynamically responsive with each question linked to an actionable care pathway. The company estimates that 10% of global health expenditure per annum is spent on diabetes, which is predicted to rise to $825 billion by 2030. Indirect costs from premature death, disability, and diabetes-related health complications add an additional 35% more to this number. Spotlight intends for its AQ to help reduce expenditure and healthcare burden while improving the quality of care and health outcomes. The company will use the investment to support early revenue generation, team expansion and stimulate Research and Development (R&D) tools to cover more diseases like CVD, IBD, chronic pain, and cancers.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £69,682
PlusGuidance is an online counselling/therapy platform that gives people immediate access to counselling. It provides secure video, voice, IM and email sessions directly through the site, and booking in-person sessions too. Our Mission - Immediate access to counselling for everyone. Business Model - Software-as-a-Service for counsellors, who pay a monthly fee to use secure online sessions, practice management tools to manage their clients, and a public web profile in our directory.
days to go: Expired investment: £64,987
Capital Physio is one of the UK’s fastest growing providers of retail physiotherapy. Since inception in 2012, the group has opened 17 clinics as part of a highly scalable and growth driven business model.  
days to go: Expired investment: £6,210
PremSocial is a social media platform for English football, specifically the Premier League and the Football League. PremSocial aim to provide fans of these 92 teams with an engaging online community. They will also gather, analyse and distribute unique opinion data.
days to go: Expired investment: £14,160
Pretty Athletic offers award-winning skincare solutions for athletic and active women. It makes high-performance, effective, and natural skin-care solutions for active women who sweat and experience exercise-related skincare problems. In 2018, the company's product Workout Glow was awarded the Pure Beauty Gold award for Best New Natural Face Product. It has now sold more than 15,000 units since its launch. Pretty Athletic has also collaborated with many brands such as Paola's Body Barre and Lululemon. With the proceeds, the company will intend to improve its Research & Development, Sales, and Packaging.
days to go: Expired investment: £62,748
The City Cycle Hub Limited provides a secure location to active commuters to store their bikes. Additionally, the company offers shower, changing and other related services. City Cycle is seeking £810,000 of new investment to open and establish the first City Cycle Hub in London. The management is targeting an exit valuation of £17m in 2022.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph